Aberrant Glycosylation of <scp>IgG</scp> in Children With Active Lupus Nephritis Alters Podocyte Metabolism and Causes Podocyte Injury

Aberrant IgG glycosylation develops in children with LN and adversely alters podocyte metabolism, rendering these cells vulnerable to injury. Successful treatment reverses IgG glycosylation to patterns comparable to those in patients with nonrenal SLE. These data lay a strong foundation for larger translational studies evaluating the potential of IgG glycosylation as a predictive and pharmacodynamic biomarker for LN. This work also supports a need for the development of approaches to control the aberrant glycosylation of self-targeting IgG in patients with LN as a mechanism to minimize podocytopathy.

Authors

Institutions

Publication Details

Journal
Arthritis & Rheumatology
Published
2025-04-29
DOI
https://doi.org/10.1002/art.43200
Citations
6
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
8.58

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Aberrant Glycosylation of IgG in Children With Active Lupus Nephritis Alters Podocyte Metabolism and Causes Podocyte Injury

Richard D. Cummings, George C. Tsokos, Rhea Bhargava, Prasad V. G. Katakam et al.
6 citations
Arthritis & Rheumatology
Renal Diseases and Glomerulopathies
8.58
article

Aberrant Glycosylation of IgG in Children With Active Lupus Nephritis Alters Podocyte Metabolism and Causes Podocyte Injury

Richard D. Cummings, George C. Tsokos, Rhea Bhargava, Prasad V. G. Katakam, Rohit Upadhyay, Scott E. Wenderfer, Maria Tsokos, Hua He, Tianshou Zhao, Jing Chen
article en
6 citations

Abstract

Aberrant IgG glycosylation develops in children with LN and adversely alters podocyte metabolism, rendering these cells vulnerable to injury. Successful treatment reverses IgG glycosylation to patterns comparable to those in patients with nonrenal SLE. These data lay a strong foundation for larger translational studies evaluating the potential of IgG glycosylation as a predictive and pharmacodynamic biomarker for LN. This work also supports a need for the development of approaches to control the aberrant glycosylation of self-targeting IgG in patients with LN as a mechanism to minimize podocytopathy.

Arthritis & RheumatologyVol. 77(10)
Tulane University (US), Beth Israel Deaconess Medical Center (US), Harvard University (US), University of British Columbia (CA)
National Institute of Allergy and Infectious Diseases
Good health and well-being
Openalex Percentile: Top 2%
Renal Diseases and Glomerulopathies
8.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.